177 related articles for article (PubMed ID: 29170185)
1. Dysosmia and dysgeusia associated with duloxetine.
Yoshida K; Fukuchi T; Sugawara H
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170185
[TBL] [Abstract][Full Text] [Related]
2. Taste and Smell Disturbance Resulting From Midodrine.
Horger S; Kandrac S; Longyhore DS
J Pharm Pract; 2016 Dec; 29(6):571-573. PubMed ID: 26811341
[TBL] [Abstract][Full Text] [Related]
3. Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia.
Amoako AO; Brown C; Riley T
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25911354
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine Induced Hyponatremia.
Şahan E; Parlakkaya Yıldız FB
Turk Psikiyatri Derg; 2019; 30(4):287-289. PubMed ID: 32594491
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic drug-induced smell and taste disturbances: A case report and literature review.
Che X; Li Y; Fang Y; Reis C; Wang H
Medicine (Baltimore); 2018 Jul; 97(29):e11112. PubMed ID: 30024498
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease.
Nagamine T
Asian J Psychiatr; 2020 Apr; 50():102031. PubMed ID: 32272360
[No Abstract] [Full Text] [Related]
7. Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature.
Gicquel C; Moulis F; Chenaf C; Gouraud A; Drici M; Bondon-Guitton E; Montastruc F; Montastruc JL
Eur J Clin Pharmacol; 2017 Sep; 73(9):1197-1198. PubMed ID: 28639120
[No Abstract] [Full Text] [Related]
8. Duloxetine-Associated Acute Laryngeal Dystonia: A Case Report.
Dagklis IE; Rokkou I; Kazis D; Bostantjopoulou S
J Clin Psychopharmacol; 2019; 39(6):678-679. PubMed ID: 31688398
[No Abstract] [Full Text] [Related]
9. Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain.
Nagamine T
Psychiatry Clin Neurosci; 2018 Jan; 72(1):45-46. PubMed ID: 29064131
[No Abstract] [Full Text] [Related]
10. Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.
Henry NL; Unger JM; Till C; Schott AF; Crew KD; Lew DL; Fisch MJ; Moinpour CM; Wade JL; Hershman DL
Cancer; 2019 Jun; 125(12):2123-2129. PubMed ID: 30861098
[TBL] [Abstract][Full Text] [Related]
11. Acute Urinary Retention and Acute Kidney Injury After Duloxetine Treatment: A Rare Case Report.
Aktürk Esen S; Gül CB; Kahvecioğlu S; Aktaş N; Esen İ
J Clin Psychopharmacol; 2019; 39(3):279-281. PubMed ID: 30908353
[No Abstract] [Full Text] [Related]
12. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
Islin J; Munkboel CH; Styrishave B
Toxicol In Vitro; 2018 Mar; 47():63-71. PubMed ID: 29100959
[TBL] [Abstract][Full Text] [Related]
13. Case Report of Probable Duloxetine-Induced Hyperosmia.
Gündoğmuş İ; Ünsal C; Taşci AB; Uçar H; Bolu A; Öznur T; Özmenler KN
Clin Neuropharmacol; 2020; 43(2):54. PubMed ID: 32106138
[No Abstract] [Full Text] [Related]
14. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
Yılmaz R; Üstün D; Tuncer Uzun S; Reisli R; Türk Ş
Agri; 2018 Oct; 30(4):199-201. PubMed ID: 30403275
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
[TBL] [Abstract][Full Text] [Related]
16. [Duloxetine Associated Galactorrhea and Hyperprolactinemia: A Case Report].
Özkan HM
Turk Psikiyatri Derg; 2020; 31(4):294-296. PubMed ID: 33454942
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine lessens joint pain in early-stage breast cancer.
Tanday S
Lancet Oncol; 2017 Jan; 18(1):e10. PubMed ID: 27989429
[No Abstract] [Full Text] [Related]
18. Suspected duloxetine-induced restless legs syndrome phenotypic variant: a case report.
Shao Y; Chen Y; Wang S; Li C; Sun H; Sun X
BMC Psychiatry; 2024 May; 24(1):349. PubMed ID: 38730422
[TBL] [Abstract][Full Text] [Related]
19. Mixed lymphocytic and collagenous inflammation of the entire gastrointestinal tract under therapy with serotonin and norepinephrine reuptake inhibitors.
Varelas AI; Fürst S; Langner C
Virchows Arch; 2022 Nov; 481(5):779-783. PubMed ID: 35655103
[TBL] [Abstract][Full Text] [Related]
20. Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan.
Sheng WH; Liu WD; Wang JT; Chang SY; Chang SC
J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):311-317. PubMed ID: 33139151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
